Cyclin D1 Protein Expression in Lung Cancer

Yonsei Medical Journal

Volumn 37, Issue 2, 1996, Pages 142-150

  Yang, Woo Ick ^a   Chung, Kyung Young ^a   Shin, Dong Hwan ^a   Kim, Yung Bae ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Inha University   (South Korea)

Author keywords

Cyclin D1 protein; Immunohistochemistry; Lung cancer

Indexed keywords

CYCLIN D1; CYCLINE; ONCOPROTEIN;

ARTICLE; CANCER STAGING; CHEMISTRY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MORTALITY; PATHOLOGY;

CYCLIN D1; CYCLINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEOPLASM STAGING; ONCOGENE PROTEINS;

EID: 0030116171     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1996.37.2.142     Document Type: Article

References (25)

1. Bartkova J, Lukas J, Strauss M, Bartek J: Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein. J Pathol 172: 237-245, 1994
2. Berenson JR, Koga H, Yang J, Pearl J, Holmes EC, Figlin R, Lung Caner Study Group: Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. Oncogene 5: 1343-1348, 1990
3. Betticher DC, Heighway J, Hasleton PS, Altermatt HJ, Ryder WD, Cerny T, Thatcher N: Prognostic significance of CCNDI (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer 73: 294-300, 1996
4. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, Heighway J: Alternate splicing produce a novel cyclin D1 transcript. Oncogene 11: 1005-1011, 1995
5. Bodrug SE, Warner BJ, Bath ML, Lindemans GJ, Harris AW, Adams JM: Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with myc gene. EMBO 13: 2124-2130, 1994
6. Buckley MF, Sweeney KJE, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CKW, Musgrove EA, Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127-2133, 1993
7. Callender T, El-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG: PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 74: 152-158, 1994
8. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA: Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91: 709-713, 1994
9. Lammie G, Peters G: Chromosome 11q13 abnormalities in human cancers. Cancer Cells 3: 413-417, 1991
10. Lukas J, Bartkova J, Welcker M, Peterson OW, Peters G, Strauss M, Bartek J: Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. Oncogene 10: 2125-2134, 1995
11. Matshushime H, Roussel MF, Ashmun RA, Sherr CJ: Colony stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65: 701-713, 1991
12. McIntosh GG, Anderson JJ, Milton I, Steward M, Parr AH, Thomas MD, Henry JA, Angus B, Lennard TWJ, Home CHW: Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 11: 885-891, 1995
13. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A: Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55: 975-978, 1995
14. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JM, Kronenberg HM, Arnold A: A novel cyclin encoded by bell-linked candidate oncogen. Nature (Lond.) 350: 512-515, 1991
15. Muller D, Millon R, Lidereau R, Engelmann A, Bronner G, Flesh H, Eber M, Methlin G, Abecassis J: Frequent amplification of 11q13 DNA markers associated with lymph node involvement in head and neck squamous cell carcinomas. Eur J Cancer 2: 113-120, 1994
16. Rosenberg CL, Kim HG, Shows TB, Kronenberg HM, Arnold A: Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 6: 449-453, 1991
17. Schauer IE, Siriwardana S, Langan TA, Sclafani RA: Cyclin D1 overexpression vs. retinoblastoma inactivation: Implications for growth control evasion in non-small cell and small cell lung cancer. Proc Natl Acad Sci USA 91: 7827-7831, 1994
18. Schuuring E, Verhoeven E, van Tinteren H, Peterse JL, Nunnink B, Thunnissen FBJM, Devilee P, Cornelisse CJ, van de Vijver MJ, Mooi WJ, Michalides RJAM: Amplification of the genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 52: 5229-5234, 1992
19. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt E: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669-671, 1994
20. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A: Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia 7: 241-245, 1993
21. Xiong Y, Connolly T, Futcher B, Beach D: Human D-type cyclin. Cell 65: 691-699, 1991
22. Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL: Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 145: 86-96, 1994
23. Zhang SY, Caamano J, Cooper F, Guo X, Klein-Szanto AJP: Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 102: 695-698, 1994
24. Zukerberg LR, Yang WI, Arnold A, Harris NL: Cyclin D1 (PRAD1) expression in non-Hodgkin' s lymphomas: detection by immunohistochemistry. Am J Clin Pathol 103: 756-760, 1995a
25. Zukerberg LR, Yang WI, Gadd M, Thor AD, Koerner FC, Schmidt EV, Arnold A: Cyclin D1 (PRAD1) protein expression in breast cancer: Approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod Pathol 8: 560-567, 1995b